Subject to customary closing conditions, the transaction is expected to close by the end of the third quarter of 2014 for $200 million in cash, according to the news release.
St. Jude Medical expects to increase 2014 sales by approximately $10 million to $15 million after acquiring NeuroTherm, according to the news release.
More Articles on Supply Chain:
Electronic Data Interchange Market to Reach $1.7B by 2018
UDIs Offer Healthcare a Long-Overdue Way to Save Lives and Reduce Costs
Devices Can Now Be Shipped to Hospital Beds in Under 4 Hours
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
